| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/30/1998 | CN2302010Y Black plaster with new structure |
| 12/30/1998 | CN2302009Y Bezoar agkistrodon tablet |
| 12/30/1998 | CN1203527A Stable freeze-dried pharmaceutical formulation |
| 12/30/1998 | CN1203101A Health paster for treating prostatosis and preparing process thereof |
| 12/30/1998 | CN1203097A Compound ointment for treating rheumatic disease and preparing process thereof |
| 12/30/1998 | CN1203093A Chinese medicine mounting film for acupoints |
| 12/30/1998 | CN1203083A Antifissuration skin care cream for feet |
| 12/30/1998 | CN1203079A Liquid antiacid compositions |
| 12/30/1998 | CN1203078A Process for preparing synergetic antimalarial-compound naphthoquine phosphate |
| 12/30/1998 | CN1203074A External-use ointment for face and its preparing process |
| 12/30/1998 | CA2294348A1 Vaccines containing bordetella pertussis antigen |
| 12/30/1998 | CA2294148A1 Gelled composition |
| 12/30/1998 | CA2264022A1 Stable aspirin-containing preparations for external use |
| 12/29/1998 | US5854384 Process for preparing poly-α-amino acid particles |
| 12/29/1998 | US5854383 Aliphatic polyesters of trimethylene carbonate epsilon-caprolactone and glycolide |
| 12/29/1998 | US5854382 Bioresorbable compositions for implantable prostheses |
| 12/29/1998 | US5854368 Adjuvant for pharmaceutical preparations |
| 12/29/1998 | US5854336 Process for preparing silicone elastomer compositions |
| 12/29/1998 | US5854281 Preparation for percutaneous absorption |
| 12/29/1998 | US5854270 Oral compositions containing ondansetron |
| 12/29/1998 | US5854269 Nasal spray compositions |
| 12/29/1998 | US5854246 Topical ketoconazole emulsions |
| 12/29/1998 | US5854229 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 12/29/1998 | US5854226 Pharmaceutical composition |
| 12/29/1998 | US5854225 Compounds derived from cyclodextrin |
| 12/29/1998 | US5854224 Composition and method for delivery of nucleic acids |
| 12/29/1998 | US5854208 Hepatoselective pharmaceutical actives |
| 12/29/1998 | US5853763 Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissue and controlling their release |
| 12/29/1998 | US5853762 Delivery of controlled-release system(s) |
| 12/29/1998 | US5853760 Device for the controlled release of active substances |
| 12/29/1998 | US5853759 Effervescent alendronate formulation |
| 12/29/1998 | US5853758 Preparation of tablets of increased strength |
| 12/29/1998 | US5853757 Carrier for animal medication |
| 12/29/1998 | US5853756 Controlled release formulations of Ranitidine |
| 12/29/1998 | US5853755 Biphasic multilamellar lipid vesicles |
| 12/29/1998 | US5853753 Liposomes, method of preparing the same and use thereof in the preparation of drugs |
| 12/29/1998 | US5853752 Methods of preparing gas and gaseous precursor-filled microspheres |
| 12/29/1998 | US5853751 Molecular transdermal transport system |
| 12/29/1998 | US5853750 Polymerized microemulsion pressure sensitive adhesive compositions and methods of preparing and using same |
| 12/29/1998 | US5853748 Pharmaceutical compositions |
| 12/29/1998 | US5853747 Therapeutic and dietetic uses of a brain phospholipid-based complex |
| 12/29/1998 | US5853740 Delivery system for pharmaceutical agents encapsulated with oils |
| 12/29/1998 | US5853732 Pharmaceutical compositions containing kukui nut oil |
| 12/29/1998 | US5853385 Encapsulated PC12 cell transplants for treatment of Parkinson's disease |
| 12/29/1998 | US5853383 Preparation for formulations for electrotransport drug delivery |
| 12/29/1998 | US5853003 Treatment and diagnosis of respiratory disorders using fluorocarbon liquids |
| 12/29/1998 | CA2158583C Pharmaceutical composition in the form of a kit |
| 12/29/1998 | CA2143413C Local drug delivery film, for periodontal treatment |
| 12/29/1998 | CA2135203C Metering spray designed for pernasal application |
| 12/29/1998 | CA2045478C Xanthine compounds |
| 12/29/1998 | CA2028811C Aerosol preparation for external use |
| 12/24/1998 | DE19726282A1 Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern Nanoscale particles having an area surrounded by at least two shells in iron oxide-containing core |
| 12/24/1998 | DE19726264A1 Preparation of homogeneous, stable, water-free formulation(s) |
| 12/24/1998 | DE19726132A1 Oil-in-water or multiple emulsion with high concentration of dissolved ultra-violet B filter used as light-protection skin care product |
| 12/24/1998 | DE19725615A1 Zur topischen Applikation bestimmte Diclofenac-Lösung For topical application specific diclofenac solution |
| 12/24/1998 | DE19724868A1 Stable cosmetic or pharmaceutical preparation, e.g. cream |
| 12/24/1998 | DE19724696A1 Pharmazeutische Zubereitung mit drei Pelletarten Pharmaceutical composition with three pellet types |
| 12/24/1998 | DE19724444A1 Transdermal composition, especially for vitamin=A, C and E application |
| 12/23/1998 | WO1998058254A1 A method and an industrial process for determining dose-level characteristics of a multiple unit system |
| 12/23/1998 | WO1998057980A1 Peptides and compounds that bind to the il-5 receptor |
| 12/23/1998 | WO1998057917A1 METHOD FOR PRODUCING MEDICAMENTS CONTAINING HMG-CoA-REDUCTASE INHIBITORS |
| 12/23/1998 | WO1998057670A1 Oxygen delivery agents and uses for the same |
| 12/23/1998 | WO1998057648A1 Methods of increasing the bioavailability of stable crystal polymorphs of a compound |
| 12/23/1998 | WO1998057630A1 Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof |
| 12/23/1998 | WO1998057624A1 Diclofenac solution for topical application |
| 12/23/1998 | WO1998057622A1 Synergistic compositions for lycopene and vitamin e for the prevention of ldl oxidation |
| 12/23/1998 | WO1998057619A1 Aerosol deodorant-antiperspirant product |
| 12/23/1998 | WO1998057613A1 Adhesive plaster with microcapsules containing essences, and method for its preparation |
| 12/23/1998 | WO1998042327A3 Vascular remodeling agent |
| 12/23/1998 | WO1998042310A3 Fast release compressed tablet of flurbiprofen |
| 12/23/1998 | WO1998041535A3 Activation of peptides |
| 12/23/1998 | EP0885914A2 Disperse two or multi-phase systems linked by covalent bonds into a network |
| 12/23/1998 | EP0885568A1 Sugarless calcium rich gelled paste |
| 12/23/1998 | EP0885265A1 Mineral pigment microparticles covered with a chitin layer |
| 12/23/1998 | EP0885061A1 Chitin or chitin derivative microcapsules containing a hydrophobic substance, particularly a sun filter and method for preparing such microcapsules |
| 12/23/1998 | EP0885060A1 Solid and semi-solid hydrocarbon gels and uses thereof |
| 12/23/1998 | EP0885038A2 Methods and apparatus for particle precipitation and coating using near-critical and supercritical antisolvents |
| 12/23/1998 | EP0885016A1 Thermally stabilized contrast agent |
| 12/23/1998 | EP0885014A1 Pharmaceutical compositions containing buffered ortho ester polymers |
| 12/23/1998 | EP0885010A1 Intercellular adhesion molecule powder formulation |
| 12/23/1998 | EP0885002A2 Materials and methods for enhancing cellular internalization |
| 12/23/1998 | EP0792144B1 Cleaning tissues treated with water-in-lipid emulsion |
| 12/23/1998 | EP0766555B1 Nanoparticles stabilized and filterable in sterile conditions |
| 12/23/1998 | EP0759741B1 Mucoadhesive emulsions containing cyclodextrin |
| 12/23/1998 | EP0741603B1 An apparatus for coating solid particles |
| 12/23/1998 | EP0719146B1 Novel method of progesterone delivery and effect thereof |
| 12/23/1998 | EP0714300B1 Methods for modulating the human sexual response |
| 12/23/1998 | EP0665759B1 Dry powder inhaler |
| 12/23/1998 | EP0616841B1 Production method for fine granulate |
| 12/23/1998 | EP0553294B1 The manufacture of compositions for the treatment of cell proliferation disorders |
| 12/23/1998 | EP0321464B1 Coatings based on polydextrose for aqueous film coating of pharmaceutical, food and confectionery products |
| 12/23/1998 | CN2301204Y Female sterilization film |
| 12/23/1998 | CN1202830A Stabilised phospholipid compositions |
| 12/23/1998 | CN1202829A Method for preserving microoganisms |
| 12/23/1998 | CN1202827A 1,2,4-benzotriazine oxides formulations |
| 12/23/1998 | CN1202823A Hydrolysis-optimized liplid emulsions and use thereof |
| 12/23/1998 | CN1202822A Use of a THF alpha antagonist for treating neurogenic skin redness |
| 12/23/1998 | CN1202821A Compositions and methods for buccal delivery of pharmaceutical agent |
| 12/23/1998 | CN1202820A Buccal delivery of glucagon-like insulinotropic peptides |
| 12/23/1998 | CN1202819A Composition for transdermal delivery |